Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1458)
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
24,000
Price
$95.86
Total Value
$2.30M
Shares Held After
63,209
% of Holdings
27.5%
Emergent BioSolutions Inc. (EBS)
DeGolyer Donald W — Director
Shares
17,800
Price
$7.09
Total Value
$126.20K
Shares Held After
111,921
% of Holdings
13.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
435
Price
$64.16
Total Value
$27.91K
Shares Held After
105,272
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$545.50
Total Value
$43.64K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
842
Price
$544.75
Total Value
$458.68K
Shares Held After
324,523
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$543.99
Total Value
$303.55K
Shares Held After
325,365
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$542.49
Total Value
$65.10K
Shares Held After
325,923
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
380
Price
$541.55
Total Value
$205.79K
Shares Held After
326,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,054
Price
$540.68
Total Value
$1.11M
Shares Held After
326,423
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,606
Price
$539.68
Total Value
$866.72K
Shares Held After
328,477
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,088
Price
$538.61
Total Value
$586.01K
Shares Held After
330,083
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$537.58
Total Value
$71.50K
Shares Held After
331,171
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
323
Price
$536.25
Total Value
$173.21K
Shares Held After
331,304
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
734
Price
$535.71
Total Value
$393.21K
Shares Held After
331,627
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
167
Price
$534.30
Total Value
$89.23K
Shares Held After
332,361
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$533.14
Total Value
$114.63K
Shares Held After
332,528
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$531.94
Total Value
$170.22K
Shares Held After
332,743
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.13
Total Value
$127.23K
Shares Held After
333,063
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$528.72
Total Value
$190.34K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$527.90
Total Value
$147.81K
Shares Held After
333,663
% of Holdings
0.1%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
32,479
Price
$8.30
Total Value
$269.58K
Shares Held After
299,271
% of Holdings
9.8%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
23,463
Price
$7.20
Total Value
$168.88K
Shares Held After
1,519,606
% of Holdings
1.5%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
7,183,013
Price
$35.05
Total Value
$251.76M
Shares Held After
77,225,493
% of Holdings
8.5%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
2,088,987
Price
$35.05
Total Value
$73.22M
Shares Held After
16,453,806
% of Holdings
11.3%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
27,659
Price
$10.64
Total Value
$294.29K
Shares Held After
613,187
% of Holdings
4.3%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
4,166
Price
$55.07
Total Value
$229.41K
Shares Held After
43,381
% of Holdings
8.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
21,000
Price
$96.81
Total Value
$2.03M
Shares Held After
87,209
% of Holdings
19.4%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$61.38
Total Value
$214.83K
Shares Held After
153,902
% of Holdings
2.2%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
272
Price
$13.61
Total Value
$3.70K
Shares Held After
709,153
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
58,061
Price
$12.92
Total Value
$750.24K
Shares Held After
709,425
% of Holdings
7.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,638
Price
$64.03
Total Value
$104.88K
Shares Held After
105,272
% of Holdings
1.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
2,403
Price
$15.00
Total Value
$36.05K
Shares Held After
49,448
% of Holdings
4.6%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
294
Price
$1.99
Total Value
$585.06
Shares Held After
81,715
% of Holdings
0.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
2,718
Price
$35.57
Total Value
$96.67K
Shares Held After
6,832
% of Holdings
28.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
3,198
Price
$35.57
Total Value
$113.74K
Shares Held After
8,038
% of Holdings
28.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
8,580
Price
$35.57
Total Value
$305.16K
Shares Held After
21,064
% of Holdings
28.9%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
45
Price
$207.46
Total Value
$9.34K
Shares Held After
562,760
% of Holdings
0.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
146
Price
$206.84
Total Value
$30.20K
Shares Held After
562,805
% of Holdings
0.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
297
Price
$205.78
Total Value
$61.12K
Shares Held After
562,951
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
290
Price
$204.80
Total Value
$59.39K
Shares Held After
563,248
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
432
Price
$203.61
Total Value
$87.96K
Shares Held After
563,538
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,017
Price
$202.32
Total Value
$205.76K
Shares Held After
563,970
% of Holdings
0.2%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
481
Price
$201.26
Total Value
$96.80K
Shares Held After
564,987
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,840
Price
$200.44
Total Value
$368.81K
Shares Held After
565,468
% of Holdings
0.3%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance&CAO
Shares
19,000
Price
$86.74
Total Value
$1.65M
Shares Held After
27,860
% of Holdings
40.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
18,000
Price
$86.74
Total Value
$1.56M
Shares Held After
145,435
% of Holdings
11.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
235,477
Price
$27.13
Total Value
$6.39M
Shares Held After
0
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
MILNE GEORGE M JR — Director
Shares
30,000
Price
$27.70
Total Value
$830.90K
Shares Held After
782,881
% of Holdings
3.7%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
7,394
Price
$8.12
Total Value
$60.07K
Shares Held After
545,493
% of Holdings
1.3%
SOPHiA GENETICS SA (SOPH)
Muken Ross — Director
Shares
9,838
Price
$8.13
Total Value
$79.97K
Shares Held After
660,391
% of Holdings
1.5%
Showing 1–50 of 1458 transactions (page 1 of 30)